Consulta pública avalia inclusão no SUS de remédio para hipertensão

Buobe IA context · why it matters

The public consultation on the inclusion of sotatercept in the SUS for treating adult patients with pulmonary arterial hypertension (PAH) — Healthcare providers and the public can provide input to potentially expand treatment options for PAH.
Contributions from civil society and medical community will be accepted until October 17th — This could lead to improved access to sotatercept, a drug that targets vascular cell growth in PAH patients.

Published by

agenciabrasil.ebc.com.br

on •1 min read

A Comissão Nacional de Incorporação de Tecnologias no Sistema Único de Saúde (Conitec) abriu consulta pública para avaliar a inclusão do medicamento sotatercepte na rede pública, para tratamento de pacientes adultos com hipertensão arterial pulmonar (HAP).

sus hipertensão remédio

Learn more